Literature DB >> 11790064

Health decision aids to facilitate shared decision making in office practice.

Michael J Barry1.   

Abstract

For medical decisions with more than one reasonable option, patient participation in decision making is often necessary to optimally match management decisions with patient preferences. Health decision aids are designed to facilitate shared decision making by helping patients and their physicians choose among reasonable clinical options. Although these aids vary in content, common denominators are the presentation of more than one reasonable strategy for a clinical management question and a description of the possible outcomes of the various options. Although the number of published randomized trials assessing the impact of health decision aids on the quality of medical decisions is limited (but growing), various types of decision aids do generally appear to inform patients about their treatment options better than "usual care" can. Little evidence is available to determine whether one type of decision aid is optimal, but more complicated programs seem to have larger effects. The cost-effectiveness of decision aids has not been studied, although it is enticing to think that the pattern of more conservative decisions by users of some decision aids could reduce medical care costs in a manner that is dictated by patient preferences.

Entities:  

Keywords:  Empirical Approach; Professional Patient Relationship

Mesh:

Substances:

Year:  2002        PMID: 11790064     DOI: 10.7326/0003-4819-136-2-200201150-00010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  69 in total

1.  The use of multi-criteria decision analysis weight elicitation techniques in patients with mild cognitive impairment: a pilot study.

Authors:  Janine A van Til; James G Dolan; Anne M Stiggelbout; Karin C G M Groothuis; Maarten J Ijzerman
Journal:  Patient       Date:  2008-04-01       Impact factor: 3.883

Review 2.  Evidence, values, guidelines and rational decision-making.

Authors:  Bruce Barrett
Journal:  J Gen Intern Med       Date:  2011-10-05       Impact factor: 5.128

3.  Evolution of Patient Decision-Making Regarding Medical Treatment of Rheumatoid Arthritis.

Authors:  Alexandra L Mathews; Adriana Coleska; Patricia B Burns; Kevin C Chung
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-03       Impact factor: 4.794

Review 4.  Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA Guidelines.

Authors:  Seth S Martin; Laurence S Sperling; Michael J Blaha; Peter W F Wilson; Ty J Gluckman; Roger S Blumenthal; Neil J Stone
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

5.  Low-literacy interventions to promote discussion of prostate cancer: a randomized controlled trial.

Authors:  Sunil Kripalani; Jyoti Sharma; Elizabeth Justice; Jeb Justice; Cynthia Spiker; Larry E Laufman; Megan Price; Armin D Weinberg; Terry A Jacobson
Journal:  Am J Prev Med       Date:  2007-08       Impact factor: 5.043

6.  Likely consequences of increased patient choice.

Authors:  Margaret Holmes-Rovner
Journal:  Health Expect       Date:  2005-03       Impact factor: 3.377

7.  For my wellness, not just my illness: North Americans' use of dietary supplements.

Authors:  Mark Nichter; Jennifer Jo Thompson
Journal:  Cult Med Psychiatry       Date:  2006-06

8.  Moving towards shared decision making in prostate cancer screening.

Authors:  Richard M Hoffman; Deborah L Helitzer
Journal:  J Gen Intern Med       Date:  2007-07       Impact factor: 5.128

9.  Patient-provider communication in cancer screening.

Authors:  Tung T Nguyen; Stephen J McPhee
Journal:  J Gen Intern Med       Date:  2003-05       Impact factor: 5.128

10.  Perceived ambiguity about cancer prevention recommendations: associations with cancer-related perceptions and behaviours in a US population survey.

Authors:  Paul K J Han; Richard P Moser; William M P Klein
Journal:  Health Expect       Date:  2007-12       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.